Smilax Laboratories Limited

Smilax Laboratories Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24230TG2004PLC044461 Incorporated 20 October 2004 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹206.57 Cr
▼ 25.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹97 Cr
Registered with MCA
Paid-up capital
₹96.04 Cr
Issued & subscribed
Open charges
₹11.51 Cr
Satisfied ₹465.93 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
521
Latest available

About Smilax Laboratories Limited

Data last updated: 03 April 2026

Smilax Laboratories Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 20 October 2004, the company has been in operation for over 22 years.

Registered with ROC Hyderabad under CIN U24230AP2004PLC044461.

Capital: an authorised share capital of ₹97 Cr and a paid-up capital of ₹96.04 Cr. It is led by directors including Ramakrishna Reddy Munnamgi and Suryadevara Murali Krishna.

Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 12/A Phase Iii Ida Jeedimetla, Hyderabad, Telangana, India – 500055.

As per the financials filed for FY 2025, the company reported a revenue of ₹206.57 Cr, a decline of 25% compared to the previous year.

The company has a workforce of approximately 521 employees as per the latest available data.

The company is associated with 1 brand - Smilax Laboratories. As per MCA filings, the company has open charges of ₹11.51 Cr and satisfied charges of ₹465.93 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smilaxlabs.com.

Company Details of Smilax Laboratories Limited
CIN U24230TG2004PLC044461
Registration Number 044461
Incorporation Date 20 October 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No 12/A Phase Iii Ida Jeedimetla, Hyderabad, Telangana, India – 500055
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers
Company report
Smilax Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Smilax Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Smilax Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Smilax Laboratories Limited

Smilax Laboratories Limited has one previous CIN (Corporate Identification Number): U24230AP2004PLC044461. The current CIN is U24230TG2004PLC044461, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230TG2004PLC044461 Current
U24230AP2004PLC044461 Previous

Associated Brands with Smilax Laboratories Limited

Smilax Laboratories Limited operates one associated brand: Smilax Laboratories. These brands represent Smilax Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
APIs, intermediates, and pellets are manufactured by Smilax Laboratories. smilaxlabs.com

Competitors & Alternatives of Smilax Laboratories Limited

Brands and companies operating in the same space as Smilax Laboratories Limited include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Apicore Apicore APIs are manufactured and custom synthesis services are provided. Somerset, United States, United States 2004
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978
Bellen Chemistry Bellen Chemistry APIs and intermediates are researched and manufactured, specializing in heterocycles. Beijing, China, China 2007

Business Activity of Smilax Laboratories Limited

Smilax Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Smilax Laboratories Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Smilax Laboratories Limited

Smilax Laboratories Limited is currently managed by 4 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ramakrishna Reddy Munnamgi Director 25 Jun 2019 7 Years 0 Months Current
Suryadevara Murali Krishna Managing Director 01 Mar 2010 16 Years 4 Months Current
Surender Reddy Geedipalli Director 24 Sep 2021 4 Years 9 Months Current
Saibaba Reddy Eadala Director 24 Sep 2021 4 Years 9 Months Current

Financials of Smilax Laboratories Limited FY 2025 filings available

Smilax Laboratories Limited reported revenue of ₹206.57 Cr (down 25.00% YoY) for FY 2025.

Revenue · FY 2025
₹206.57 Cr ▼ 25.00%
Premium access

Ten-year financial statements for Smilax Laboratories Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Smilax Laboratories Limited

Open charges
₹11.51 Cr
Satisfied charges
₹465.93 Cr
Breakdown by lending institutions
Bank of India₹11.51 Cr
Latest charge details
DateLenderAmountStatus
29 Nov 2006 Bank of India ₹11.51 Cr Open
28 Mar 2016 Axis Bank Limited ₹85 Cr Satisfied
31 Mar 2014 Idfc Limited ₹100 Cr Satisfied
24 Mar 2014 Idfc Limited ₹37.5 Cr Satisfied
29 May 2009 Andhra Bank ₹81.89 Cr Satisfied

Total charge records: 9 View all charges

Employees and EPFO Compliance at Smilax Laboratories Limited

View historical data on people associated with Smilax Laboratories Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Smilax Laboratories Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Smilax Laboratories Limited

Premium access

GST registrations and filing compliance for Smilax Laboratories Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Smilax Laboratories Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Smilax Laboratories Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Smilax Laboratories Limited

Premium access

MSME payment history for Smilax Laboratories Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Smilax Laboratories Limited

Premium access

Corporate group structure for Smilax Laboratories Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Smilax Laboratories Limited

Premium access

MCA filings and documents for Smilax Laboratories Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Smilax Laboratories Limited

Activity
12 Sep 2025
Smilax Laboratories Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records.
Directors
10 Jun 2025
Radhika Jhawar was appointed as a Company Secretary on 10 Jun 2025 & has been associated with this company since 1 year 1 month.
Activity
31 Mar 2025
Smilax Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
04 Sep 2023
A charge registered on 20 Sep 2005 via Charge ID 90260299 with Axis Bank Limited was fully satisfied on 04 Sep 2023.
Charges
15 Jul 2022
A charge with Bank Of India of Rs. 11.51 Cr registered on 29 Nov 2006 with Charge ID 10027402 was modified on 15 Jul 2022.
Directors
15 Nov 2021
Pulicherla Ganesh was appointed as a CFO on 15 Nov 2021 & has been associated with this company since 4 years 8 months.

Frequently Asked Questions about Smilax Laboratories Limited

Smilax Laboratories Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 20 October 2004 (22+ years old) and is registered under CIN U24230TG2004PLC044461. The company has 521 employees.

Smilax Laboratories Limited reported revenue of ₹206.57 Cr for FY 2025 (down 25.00% YoY).

The current directors of Smilax Laboratories Limited are:

The primary industry of Smilax Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Smilax Laboratories Limited can be reached at the registered office: Plot No 12A Phase Iii Ida Jeedimetla, Hyderabad, Telangana, India – 500055, or through the website smilaxlabs.com.

The authorised capital is ₹97 Cr, and the paid-up capital is ₹96.04 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available